Dicerna pharmaceuticals tender offer
WebDec 8, 2024 · Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. ... Dicerna Pharmaceuticals, Inc., et al., Case No. 1:21-cv-10379 ... WebDec 25, 2024 · LEXINGTON, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, …
Dicerna pharmaceuticals tender offer
Did you know?
WebDec 8, 2024 · DRNA Dicerna Pharmaceuticals Inc Amended Tender Offer Statement by Third Party (sc To-t/a) ... Purchaser to purchase all of the outstanding shares of common … WebDec 28, 2024 · Novo Nordisk has been advised by the depositary for the tender offer that almost 65 million shares of Dicerna’s common stock were validly tendered and not validly withdrawn in the tender offer as of the expiration fo the tender offer at 5 p.m. ET on Dec. 27, 2024, representing approximately 82.6% of the total number of shares of Dicerna’s ...
WebAt Dicerna, we use RNA interference, or RNAi, to create medicines that silence or turn off the genes that cause or contribute to disease. Using our GalXC™ and GalXC-Plus™ technologies , we aim to develop safe, … WebMost Recent Annual Report. MOST RECENT 2024 Annual Report and Form 10K. View PDF View Form 10K (HTML) Dicerna Pharmaceuticals Inc does not currently have any …
WebNov 18, 2024 · Upon the successful completion of the tender offer, Novo Nordisk’s acquisition subsidiary will be merged into Dicerna, and any remaining shares of common … WebFollowing the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of common stock of Dicerna at a price of USD 38.25 per share in cash, without interest and less any applicable tax withholding. ... Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research ...
WebNovo Nordisk announces completion of Dicerna Pharmaceuticals acquisition. Bagsværd, Denmark, 28 December 2024 – Novo Nordisk today announced that the acquisition of …
WebJan 2, 2024 · LEXINGTON, Mass.–(BUSINESS WIRE)–Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2024, has been completed.Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of … greenbriar woods corporationWebUnder the terms of the agreement, Novo Nordisk, through a subsidiary, will initiate a tender offer to acquire all outstanding shares of Dicerna common stock at a price of $38.25 per … greenbriar washington dcWebDec 25, 2024 · Novo Nordisk has filed a Tender Offer Statement on Schedule TO with the SEC containing an offer to purchase all of the outstanding shares of Dicerna common … flowers that you can blow awayWebDec 27, 2024 · As previously announced on November 18, 2024, Novo Nordisk commenced a cash tender offer to purchase all outstanding shares of Dicerna common stock for $38.25 per share in cash, without interest ... flowers that you\u0027re able to put in vases ff14WebDec 27, 2024 · Novo Nordisk has filed a Tender Offer Statement on Schedule TO with the SEC containing an offer to purchase all of the outstanding shares of Dicerna common stock for $38.25 per share, and Dicerna ... flowers the beauty of natureWebWe go right to the source. Genes play a primary role in thousands of diseases. At Dicerna, we use our proprietary GalXC™ platform to develop RNAi therapies that aim to target … flowers that you can printWebNov 19, 2024 · Novo Nordisk has signed a definitive agreement for the acquisition of Dicerna Pharmaceuticals, including its ribonucleic acid interference (RNAi) platform, for … greenbriar woods apartments fullerton ca